Newsroom

RAYNHAM, Mass.--(BUSINESS WIRE)--DePuy Synthes, a global leader in orthopaedic technologies and solutions, today announced a definitive agreement to acquire selective rights to develop, manufacture and commercialize Gemtrack technology across its Joints portfolio, including shoulder, hip and knee, for both navigation and robotic applications. Gemtrack is a proprietary tracking technology developed by MinMaxMedical (MMM), a Grenoble-based pioneer in medtech and surgical innovation. Pending succe...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficia...

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on Tuesday, May 26, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update on Wednesday, May 27th, at 8:00 a.m. Eastern Time. Update Call Details Veradigm plans to issue a press release afte...

INCLINE VILLAGE, Nev.--(BUSINESS WIRE)--Socure, the leading trust infrastructure for global identity and risk intelligence, and Prism Data, a top cash-flow underwriting analytics company, today announced a strategic partnership to bring market-leading cash flow analytics directly into Socure RiskOS®, Socure’s unified fraud, compliance, and risk decisioning platform. By embedding Prism’s CashScore® and intelligence suite into the Socure RiskOS ecosystem, the partnership enables lenders to move b...

NEW YORK & TORRANCE, Calif.--(BUSINESS WIRE)--Thesis Care and Unio Health Partners partner to deploy AI care team agents across Unio's California specialty practices serving 500,000+ patients....

WOODBURY, N.Y.--(BUSINESS WIRE)--BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Delphia Therapeutics, Inc. (Delphia), a biopharmaceutical company pioneering an innovative new area of cancer biology – activation lethality – which targets cancer's surprising vulnerability to oncogene overactivation, today announced the appointment of David P. Kerstein, M.D., as chief medical officer. Dr. Kerstein brings significant experience in oncology drug development across early- and late-stage precision oncology programs. “David is an accomplished phy...

NEW YORK--(BUSINESS WIRE)--BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), today announced it has secured initial commitments for $4.1M of convertible preferred stock financing, with additional commitments anticipated to bring total proceeds to $5.0M (the "Financing"). Proceeds from the Financing will be used to bolster the Company’s digital asset treasury and will provide working capital in support of a comprehensive strategic review. With the anticipated proceeds, the Company exp...

LEAWOOD, Kan.--(BUSINESS WIRE)--AMC Entertainment (NYSE: AMC), the largest theatrical exhibitor in the United States and in the world, welcomed more than 5.0 million moviegoers to its theatres across the United States and to its ODEON Cinemas locations internationally during the U.S. Memorial Day holiday weekend, spanning Thursday through Monday. At its U.S. locations, AMC enjoyed its highest-attended Thursday-through-Monday period of 2026, reflecting continued strong momentum at the box office...

NAARDEN, The Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V. today announced a Data Use Agreement (DUA) under which Prilenia will provide CHDI with clinical data from the placebo arms of its PRIDE and PROOF studies for the purpose of advancing research into treatments for Huntington's disease (HD). “Collaboration which balances scientific rigor with data openness is an ethical and scientific imperative. Sharing data is key to accelerating and advancing knowledge and un...